US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist
  • 394.100
  • +5.880+1.51%
Close Mar 27 16:00 ET
  • 394.100
  • 0.0000.00%
Pre 08:12 ET
28.85BMarket Cap50.01P/E (TTM)

West Pharmaceutical Services Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
2.18%2.95B
3.29%732M
8.81%747.4M
-2.27%753.8M
-0.47%716.6M
1.95%2.89B
-3.02%708.7M
-2.77%686.9M
6.59%771.3M
7.35%720M
Operating revenue
2.18%2.95B
3.29%732M
8.81%747.4M
-2.27%753.8M
-0.47%716.6M
1.95%2.89B
-3.02%708.7M
-2.77%686.9M
6.59%771.3M
7.35%720M
Cost of revenue
3.99%1.82B
1.61%453.8M
9.60%459.1M
2.80%462.4M
2.27%445.3M
5.73%1.75B
3.81%446.6M
0.14%418.9M
10.11%449.8M
9.18%435.4M
Gross profit
-0.62%1.13B
6.14%278.2M
7.57%288.3M
-9.36%291.4M
-4.67%271.3M
-3.37%1.14B
-12.81%262.1M
-7.01%268M
2.03%321.5M
4.67%284.6M
Operating expense
12.36%421.8M
6.69%108.4M
31.91%105.4M
9.38%104.9M
5.20%103.1M
-9.67%375.4M
-9.04%101.6M
-23.90%79.9M
-9.95%95.9M
6.06%98M
Selling and administrative expenses
11.52%353.4M
5.02%90M
34.24%89M
8.47%88.4M
3.12%86M
-12.65%316.9M
-12.55%85.7M
-27.86%66.3M
-12.08%81.5M
3.99%83.4M
Research and development costs
16.92%68.4M
15.72%18.4M
20.59%16.4M
14.58%16.5M
17.12%17.1M
10.80%58.5M
16.06%15.9M
3.82%13.6M
4.35%14.4M
19.67%14.6M
Operating profit
-7.02%707.4M
5.79%169.8M
-2.76%182.9M
-17.33%186.5M
-9.86%168.2M
0.08%760.8M
-15.03%160.5M
2.67%188.1M
8.15%225.6M
3.96%186.6M
Net non-operating interest income expense
778.57%19M
583.33%8.2M
942.86%5.9M
264.29%2.3M
236.84%2.6M
61.11%-2.8M
152.17%1.2M
50.00%-700K
33.33%-1.4M
-5.56%-1.9M
Non-operating interest income
449.02%28M
224.14%9.4M
486.67%8.8M
1,150.00%5M
1,500.00%4.8M
410.00%5.1M
866.67%2.9M
275.00%1.5M
--400K
200.00%300K
Non-operating interest expense
13.92%9M
-29.41%1.2M
31.82%2.9M
50.00%2.7M
0.00%2.2M
-3.66%7.9M
-34.62%1.7M
22.22%2.2M
-14.29%1.8M
15.79%2.2M
Other net income (expense)
63.64%-28.4M
70.30%-9.8M
96.48%-1.8M
-230.00%-3.9M
-516.13%-12.9M
-1,804.88%-78.1M
-602.13%-33M
-7,214.29%-51.2M
-26.83%3M
210.71%3.1M
Gain on sale of security
-291.07%-10.7M
-1,100.00%-7.2M
-285.71%-1.3M
-143.75%-700K
-138.46%-1.5M
80.65%5.6M
-200.00%-600K
275.00%700K
-38.46%1.6M
1,200.00%3.9M
Special income (charges)
37.27%-20.7M
95.07%-1.5M
-44.83%-4.2M
-409.09%-3.4M
-1,325.00%-11.4M
-254.84%-33M
-473.58%-30.4M
-314.29%-2.9M
178.57%1.1M
80.95%-800K
-Less:Restructuring and merger&acquisition
-101.87%-500K
-104.65%-1.2M
-53.33%700K
76.92%-300K
-87.50%100K
624.32%26.8M
8,500.00%25.8M
200.00%1.5M
-208.33%-1.3M
-80.49%800K
-Less:Impairment of capital assets
54.84%9.6M
-41.30%2.7M
150.00%3.5M
650.00%1.5M
--11.3M
10.71%6.2M
-8.00%4.6M
600.00%1.4M
0.00%200K
--0
-Gain on sale of property,plant,equipment
---11.6M
--0
--0
---2.2M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
105.92%3M
45.00%-1.1M
107.55%3.7M
-33.33%200K
----
-2,514.29%-50.7M
---2M
-12,350.00%-49M
-89.66%300K
----
Income before tax
2.66%698M
30.69%168.2M
37.30%187M
-18.62%184.9M
-15.92%157.9M
-9.21%679.9M
-29.25%128.7M
-24.79%136.2M
7.68%227.2M
7.38%187.8M
Income tax
6.63%122.3M
19.38%34.5M
44.12%29.4M
-21.27%34.8M
11.32%23.6M
7.00%114.7M
-15.50%28.9M
70.00%20.4M
36.84%44.2M
-26.13%21.2M
Earnings from equity interest net of tax
-14.49%17.7M
3.13%3.3M
-22.92%3.7M
-9.09%5M
-20.83%5.7M
2.99%20.7M
--3.2M
-26.15%4.8M
-36.05%5.5M
44.00%7.2M
Net income
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
-19.45%140M
-11.47%585.9M
-30.26%103M
-31.32%120.6M
0.64%188.5M
14.95%173.8M
Net income continuous Operations
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
-19.45%140M
-11.47%585.9M
-30.26%103M
-31.32%120.6M
0.64%188.5M
14.95%173.8M
Minority interest income
Net income attributable to the parent company
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
-19.45%140M
-11.47%585.9M
-30.26%103M
-31.32%120.6M
0.64%188.5M
14.95%173.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.28%593.4M
33.01%137M
33.75%161.3M
-17.72%155.1M
-19.45%140M
-11.47%585.9M
-30.26%103M
-31.32%120.6M
0.64%188.5M
14.95%173.8M
Basic earnings per share
1.40%7.98
34.06%1.85
33.95%2.17
-17.79%2.08
-19.66%1.88
-11.47%7.87
-30.30%1.38
-31.65%1.62
0.00%2.53
14.71%2.34
Diluted earnings per share
1.94%7.88
34.56%1.83
34.59%2.14
-16.94%2.06
-19.21%1.85
-10.84%7.73
-29.53%1.36
-31.17%1.59
0.40%2.48
15.08%2.29
Dividend per share
5.48%0.77
5.26%0.2
5.56%0.19
5.56%0.19
5.56%0.19
5.80%0.73
5.56%0.19
5.88%0.18
5.88%0.18
5.88%0.18
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 2.18%2.95B3.29%732M8.81%747.4M-2.27%753.8M-0.47%716.6M1.95%2.89B-3.02%708.7M-2.77%686.9M6.59%771.3M7.35%720M
Operating revenue 2.18%2.95B3.29%732M8.81%747.4M-2.27%753.8M-0.47%716.6M1.95%2.89B-3.02%708.7M-2.77%686.9M6.59%771.3M7.35%720M
Cost of revenue 3.99%1.82B1.61%453.8M9.60%459.1M2.80%462.4M2.27%445.3M5.73%1.75B3.81%446.6M0.14%418.9M10.11%449.8M9.18%435.4M
Gross profit -0.62%1.13B6.14%278.2M7.57%288.3M-9.36%291.4M-4.67%271.3M-3.37%1.14B-12.81%262.1M-7.01%268M2.03%321.5M4.67%284.6M
Operating expense 12.36%421.8M6.69%108.4M31.91%105.4M9.38%104.9M5.20%103.1M-9.67%375.4M-9.04%101.6M-23.90%79.9M-9.95%95.9M6.06%98M
Selling and administrative expenses 11.52%353.4M5.02%90M34.24%89M8.47%88.4M3.12%86M-12.65%316.9M-12.55%85.7M-27.86%66.3M-12.08%81.5M3.99%83.4M
Research and development costs 16.92%68.4M15.72%18.4M20.59%16.4M14.58%16.5M17.12%17.1M10.80%58.5M16.06%15.9M3.82%13.6M4.35%14.4M19.67%14.6M
Operating profit -7.02%707.4M5.79%169.8M-2.76%182.9M-17.33%186.5M-9.86%168.2M0.08%760.8M-15.03%160.5M2.67%188.1M8.15%225.6M3.96%186.6M
Net non-operating interest income expense 778.57%19M583.33%8.2M942.86%5.9M264.29%2.3M236.84%2.6M61.11%-2.8M152.17%1.2M50.00%-700K33.33%-1.4M-5.56%-1.9M
Non-operating interest income 449.02%28M224.14%9.4M486.67%8.8M1,150.00%5M1,500.00%4.8M410.00%5.1M866.67%2.9M275.00%1.5M--400K200.00%300K
Non-operating interest expense 13.92%9M-29.41%1.2M31.82%2.9M50.00%2.7M0.00%2.2M-3.66%7.9M-34.62%1.7M22.22%2.2M-14.29%1.8M15.79%2.2M
Other net income (expense) 63.64%-28.4M70.30%-9.8M96.48%-1.8M-230.00%-3.9M-516.13%-12.9M-1,804.88%-78.1M-602.13%-33M-7,214.29%-51.2M-26.83%3M210.71%3.1M
Gain on sale of security -291.07%-10.7M-1,100.00%-7.2M-285.71%-1.3M-143.75%-700K-138.46%-1.5M80.65%5.6M-200.00%-600K275.00%700K-38.46%1.6M1,200.00%3.9M
Special income (charges) 37.27%-20.7M95.07%-1.5M-44.83%-4.2M-409.09%-3.4M-1,325.00%-11.4M-254.84%-33M-473.58%-30.4M-314.29%-2.9M178.57%1.1M80.95%-800K
-Less:Restructuring and merger&acquisition -101.87%-500K-104.65%-1.2M-53.33%700K76.92%-300K-87.50%100K624.32%26.8M8,500.00%25.8M200.00%1.5M-208.33%-1.3M-80.49%800K
-Less:Impairment of capital assets 54.84%9.6M-41.30%2.7M150.00%3.5M650.00%1.5M--11.3M10.71%6.2M-8.00%4.6M600.00%1.4M0.00%200K--0
-Gain on sale of property,plant,equipment ---11.6M--0--0---2.2M------0--0--0--0----
Other non- operating income (expenses) 105.92%3M45.00%-1.1M107.55%3.7M-33.33%200K-----2,514.29%-50.7M---2M-12,350.00%-49M-89.66%300K----
Income before tax 2.66%698M30.69%168.2M37.30%187M-18.62%184.9M-15.92%157.9M-9.21%679.9M-29.25%128.7M-24.79%136.2M7.68%227.2M7.38%187.8M
Income tax 6.63%122.3M19.38%34.5M44.12%29.4M-21.27%34.8M11.32%23.6M7.00%114.7M-15.50%28.9M70.00%20.4M36.84%44.2M-26.13%21.2M
Earnings from equity interest net of tax -14.49%17.7M3.13%3.3M-22.92%3.7M-9.09%5M-20.83%5.7M2.99%20.7M--3.2M-26.15%4.8M-36.05%5.5M44.00%7.2M
Net income 1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M-19.45%140M-11.47%585.9M-30.26%103M-31.32%120.6M0.64%188.5M14.95%173.8M
Net income continuous Operations 1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M-19.45%140M-11.47%585.9M-30.26%103M-31.32%120.6M0.64%188.5M14.95%173.8M
Minority interest income
Net income attributable to the parent company 1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M-19.45%140M-11.47%585.9M-30.26%103M-31.32%120.6M0.64%188.5M14.95%173.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.28%593.4M33.01%137M33.75%161.3M-17.72%155.1M-19.45%140M-11.47%585.9M-30.26%103M-31.32%120.6M0.64%188.5M14.95%173.8M
Basic earnings per share 1.40%7.9834.06%1.8533.95%2.17-17.79%2.08-19.66%1.88-11.47%7.87-30.30%1.38-31.65%1.620.00%2.5314.71%2.34
Diluted earnings per share 1.94%7.8834.56%1.8334.59%2.14-16.94%2.06-19.21%1.85-10.84%7.73-29.53%1.36-31.17%1.590.40%2.4815.08%2.29
Dividend per share 5.48%0.775.26%0.25.56%0.195.56%0.195.56%0.195.80%0.735.56%0.195.88%0.185.88%0.185.88%0.18
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg